Trial Outcomes & Findings for Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder (NCT NCT04076644)

NCT ID: NCT04076644

Last Updated: 2023-01-04

Results Overview

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block, scale is 0-27 with 0=no depression, 27=severe depression

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

11 participants

Primary outcome timeframe

given at monthly intervals for 12 months

Results posted on

2023-01-04

Participant Flow

Dates of recruitment were from 8/14/2019 to 5/21/2021. Participants were recruited from outpatient interventional psychiatry clinic at University of Missouri

Participants had up to 8 weeks to washout of their antidepressant medication, if they could not handle this washout they could not start maintenance treatment. Although two arms were originally planned due to COVID the 2nd arm consisting of group of patients who will not receive any TMS treatments was unable to be recruited.

Participant milestones

Participant milestones
Measure
TMS Treatment Arm
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
Overall Study
STARTED
11
Overall Study
COMPLETED
7
Overall Study
NOT COMPLETED
4

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
TMS Treatment Arm
n=10 Participants
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
Age, Continuous
51 years
STANDARD_DEVIATION 16.12 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
Region of Enrollment
United States
10 participants
n=5 Participants

PRIMARY outcome

Timeframe: given at monthly intervals for 12 months

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block, scale is 0-27 with 0=no depression, 27=severe depression

Outcome measures

Outcome measures
Measure
TMS Treatment Arm
n=7 Participants
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Baseline (prior to starting treatment)
5 score on a scale
Standard Deviation 4.04
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 1
6.71 score on a scale
Standard Deviation 3.05
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 2
8.14 score on a scale
Standard Deviation 3.18
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 3
9.14 score on a scale
Standard Deviation 4.67
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 4
6.14 score on a scale
Standard Deviation 4.22
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 5
7.57 score on a scale
Standard Deviation 6.06
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 6
5.85 score on a scale
Standard Deviation 3.09
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 7
5.71 score on a scale
Standard Deviation 3.49
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 8
5.86 score on a scale
Standard Deviation 4.26
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 9
7.71 score on a scale
Standard Deviation 6.12
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 10
6.43 score on a scale
Standard Deviation 5.12
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 11
7.43 score on a scale
Standard Deviation 5.83
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)
Month 12
6.86 score on a scale
Standard Deviation 4.55

PRIMARY outcome

Timeframe: given at baseline and before and after TMS treatment block for 12 months

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression

Outcome measures

Outcome measures
Measure
TMS Treatment Arm
n=7 Participants
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 3
8.43 score on a scale
Standard Deviation 4.27
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 4
6.86 score on a scale
Standard Deviation 4.55
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 5
8.86 score on a scale
Standard Deviation 5.67
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 6
7 score on a scale
Standard Deviation 6.07
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 7
5.43 score on a scale
Standard Deviation 2.82
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Baseline
4.14 score on a scale
Standard Deviation 2.36
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 1
7.57 score on a scale
Standard Deviation 3.33
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 2
8.86 score on a scale
Standard Deviation 4.09
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 8
6.29 score on a scale
Standard Deviation 3.41
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 9
8.71 score on a scale
Standard Deviation 5.90
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 10
6.86 score on a scale
Standard Deviation 5.17
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 11
7.57 score on a scale
Standard Deviation 4.66
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores
Pre Trt Month 12
8.71 score on a scale
Standard Deviation 4.91

PRIMARY outcome

Timeframe: given at baseline and before and after each TMS treatment block for 12 months

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression

Outcome measures

Outcome measures
Measure
TMS Treatment Arm
n=7 Participants
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 10
5 score on a scale
Standard Deviation 4.14
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 11
5.57 score on a scale
Standard Deviation 3.42
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 12
5.43 score on a scale
Standard Deviation 3.29
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Baseline
4.14 score on a scale
Standard Deviation 2.36
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 1
6.29 score on a scale
Standard Deviation 2.60
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 2
6 score on a scale
Standard Deviation 2.39
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 3
5.43 score on a scale
Standard Deviation 2.44
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 4
4.55 score on a scale
Standard Deviation 4.06
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 5
6.14 score on a scale
Standard Deviation 3.72
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 6
4.71 score on a scale
Standard Deviation 3.88
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 7
5 score on a scale
Standard Deviation 2.53
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 8
5.43 score on a scale
Standard Deviation 3.02
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores
Post Trt Month 9
6.57 score on a scale
Standard Deviation 4.56

Adverse Events

TMS Treatment Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Matt Schmidt

University of Missouri

Phone: 573-882-5688

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place